Changming Tan
Impact in
-
- Cardiac Valve Diseases and Treatments
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiovascular Function and Risk Factors
-
- Metabolism and Genetic Disorders
Papers in
-
- Cardiovascular Function and Risk Factors 2
- Cardiac tumors and thrombi 2
- Cardiac Valve Diseases and Treatments 2
-
- ATP Synthase and ATPases Research 2
- RNA modifications and cancer 2
- Mitochondrial Function and Pathology 2
- Co-authors
- Masoud Najafi (1 shared paper)Xiao‐Bo Liao (5 shared papers)Feng Xu (3 shared papers)Xia Xie (1 shared paper)Xinmin Zhou (4 shared papers)Jia‐Yu Zhong (2 shared papers)Fu‐Xing‐Zi Li (2 shared papers)Su‐Kang Shan (2 shared papers)
- Journals
- Inflammopharmacology (1 paper)Circulation Heart Failure (1 paper)Aging (1 paper)Frontiers in Cell and Developmental Biology (1 paper)PLoS Genetics (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Changming Tan
16 papers receiving 191 citations
Peers
Comparison fields: 5 of 52
- Cardiology and Cardiovascular Medicine 60
- Clinical Biochemistry 17
- Rehabilitation 15
- Cancer Research 23
- Immunology 26
Countries citing papers authored by Changming Tan
This map shows the geographic impact of Changming Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changming Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changming Tan more than expected).
Fields of papers citing papers by Changming Tan
This network shows the impact of papers produced by Changming Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changming Tan. The network helps show where Changming Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Changming Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 42 | |
| 2 | 2021 | 32 | |
| 3 | 2019 | 25 | |
| 4 | 2022 | 16 | |
| 5 | 2015 | 15 | |
| 6 | 2015 | 14 | |
| 7 | 2021 | 8 | |
| 8 | 2022 | 8 | |
| 9 | 2021 | 7 | |
| 10 | 2021 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2017 | 3 | |
| 13 | 2022 | 3 | |
| 14 | 2016 | 3 | |
| 15 | 2016 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 |
About Changming Tan
Changming Tan is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Surgery, Oncology and Immunology, having authored 18 papers that have together received 192 indexed citations. Recurring topics across this work include Cardiac Structural Anomalies and Repair (3 papers), MicroRNA in disease regulation (2 papers), ATP Synthase and ATPases Research (2 papers), Cardiovascular Function and Risk Factors (2 papers), Cardiac tumors and thrombi (2 papers), RNA modifications and cancer (2 papers), Mitochondrial Function and Pathology (2 papers) and Cardiac Valve Diseases and Treatments (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (60 citations), Clinical Biochemistry (17 citations), Rehabilitation (15 citations), Cancer Research (23 citations) and Immunology (26 citations). Changming Tan has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Masoud Najafi, Xiao‐Bo Liao, Feng Xu, Xia Xie, Xinmin Zhou, Jia‐Yu Zhong, Fu‐Xing‐Zi Li, Su‐Kang Shan, Feng Wu and Ling‐Qing Yuan. Their work appears in journals such as Inflammopharmacology, Circulation Heart Failure, Aging, Frontiers in Cell and Developmental Biology and PLoS Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.